Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01374685 · ClinicalTrials.gov registry record

Family Communication of Hereditary Breast and Ovarian Cancer Risk Among African Americans

A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).

Terminated
Registry status
8
Enrollment target

NCT01374685 is a clinical trial that was terminated before completion, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 8 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01374685 was terminated before completion, sponsored by National Human Genome Research Institute (NHGRI).

TERMINATED
Registry status
8 participants
Enrollment target

Study Summary

Background: \- Certain genetic mutations are linked to higher rates of cancer. It is important for people with these mutations to tell their families about it. This is because others in the family may also be at greater risk for developing these cancers. They can also pass these genes to their own children. But not much is known about how African Americans tell their family members about the results of their genetic testing. The information from this study can be used to improve genetic counseling services. These services will then be more effective in early cancer detection and prevention in the African American community. Objectives: \- To learn more about how African Americans who have tested positive for BRCA1/2 mutations tell their families about their genetic risk. Eligibility: \- African American (or of African descent) women who recently received positive test results for BRCA1/2 mutations. Design: * Participants will be screened with a basic medical history. * They will be asked general questions about their personal and family history. These include questions on marital and health insurance status, education, and income. * Those in the study will have a 45- to 60-minute phone interview. They will answer questions about how they told their family members about their genetic test results. They will also be asked what that experience was like.

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2011-06-07
Est. Completion 2016-01-07

What the Registry Record Tells You About NCT01374685

The ClinicalTrials.gov registry entry for NCT01374685 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01374685 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01374685 about?

NCT01374685 is a clinical study titled "Family Communication of Hereditary Breast and Ovarian Cancer Risk Among African Americans". Background: \- Certain genetic mutations are linked to higher rates of cancer. It is important for people with these mutations to tell their families about it. This is because others in the family may also be at greater risk for developing these cancers. They can also pass these genes to their own ...

What is the current status of trial NCT01374685?

This trial is currently terminated. The enrollment target is 8 participants. The study started on 2011-06-07. Estimated completion is 2016-01-07.

Who is sponsoring clinical trial NCT01374685?

This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.